These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8690803)

  • 1. The oxidant stress of hyperhomocyst(e)inemia.
    Loscalzo J
    J Clin Invest; 1996 Jul; 98(1):5-7. PubMed ID: 8690803
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.
    Kang SS; Wong PW; Malinow MR
    Annu Rev Nutr; 1992; 12():279-98. PubMed ID: 1503807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and consequences of hyperhomocyst(e)inemia.
    Pietrzik K; Brönstrup A
    Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
    J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.
    Malinow MR
    Circulation; 1990 Jun; 81(6):2004-6. PubMed ID: 2188759
    [No Abstract]   [Full Text] [Related]  

  • 7. Homocysteine and atherothrombosis.
    Welch GN; Loscalzo J
    N Engl J Med; 1998 Apr; 338(15):1042-50. PubMed ID: 9535670
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperhomocyst(e)inemia, related vitamins and dementias.
    Delport R
    J Nutr Health Aging; 2000; 4(4):195-6. PubMed ID: 11115799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients.
    Massy ZA; Ceballos I; Chadefaux-Vekemens B; Nguyen-Khoa T; Descamps-Latscha B; Drüeke TB; Jungers P
    Kidney Int Suppl; 2001 Feb; 78():S243-5. PubMed ID: 11169019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Moghadasian MH; McManus BM; Frohlich JJ
    Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of amino acid transformations as affected by pyridoxal phosphate enzymes].
    Braunshteĭn AE
    Vestn Akad Med Nauk SSSR; 1982; (9):3-9. PubMed ID: 6755949
    [No Abstract]   [Full Text] [Related]  

  • 12. Homocysteine, oxidative stress, and vascular disease.
    Welch GN; Upchurch GR; Loscalzo J
    Hosp Pract (1995); 1997 Jun; 32(6):81-2, 85, 88-92. PubMed ID: 9194803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent encephalopathy, reversible nerve conduction slowing, and MRI evidence of cerebral white matter disease in methylenetetrahydrofolate reductase deficiency.
    Walk D; Kang SS; Horwitz A
    Neurology; 1994 Feb; 44(2):344-7. PubMed ID: 8309589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
    Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional supplementation in the management of hyperhomocyst(e)inemia: an update.
    Shaikh A
    Indian Heart J; 2000; 52(7 Suppl):S31-34. PubMed ID: 11339438
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical points for determining moderate hyperhomocyst(e)inaemia.
    Kang SS
    Eur J Clin Invest; 1995 Nov; 25(11):806-8. PubMed ID: 8582444
    [No Abstract]   [Full Text] [Related]  

  • 18. L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells.
    Heydrick SJ; Weiss N; Thomas SR; Cap AP; Pimentel DR; Loscalzo J; Keaney JF
    Free Radic Biol Med; 2004 Mar; 36(5):632-40. PubMed ID: 14980706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-fasting plasma total homocysteine reference interval using the Vitros homocysteine assay standardized against NIST SRM 1955.
    Ogbonna G; Gottermeier G; Fox LS
    Clin Chim Acta; 2008 Feb; 388(1-2):225-7. PubMed ID: 17991431
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
    Wilcken DE; Wang XL; Wilcken B
    Circulation; 1997 Oct; 96(8):2738-40. PubMed ID: 9355925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.